Real-world comparative effectiveness of exenatide once weekly and liraglutide in patients with type 2 diabetes mellitus

被引：0
|
作者：
Saunders, W. [1 ]
Nguyen, H. Hiep [2 ]
Kalsekar, I. [2 ]
机构：
[1] Saunders Res, Charlotte, NC USA
[2] AstraZeneca, Ft Washington, MD USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
828
引用
收藏
页码：S335 / S336
页数：2
相关论文
共 50 条
  • [41] VIEW-Iran: A real-world study of liraglutide effectiveness on glycaemic control in people with type 2 diabetes mellitus
    Khamseh, M. E.
    Hosseinpanah, F.
    Malek, M.
    Damavandi, M. H.
    Thamattoor, U. K.
    Kaltoft, M. S.
    Esteghamati, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [42] Emerging utility of once-weekly exenatide in patients with type 2 diabetes
    Goud, Aditya
    Zhong, Jixin
    Rajagopalan, Sanjay
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2015, 8 : 505 - 512
  • [43] Safety of Exenatide Once Weekly in Patients with Type 2 Diabetes Treated with a Thiazolidinedione
    Norwood, Paul
    Pintilei, Ella
    Pop, Lavinia
    Liutkus, Joanne
    Choi, Suktae
    Giaconia, Joseph
    Trautman, Michael
    DIABETES, 2010, 59 : A195 - A195
  • [44] EXSCEL-Once-Weekly Exenatide Reduces Medical Resource Utilization in Patients with Type 2 Diabetes Mellitus
    Reed, Shelby D.
    Li, Yanhong
    Dakin, Helen A.
    Becker, Frauke
    Leal, Jose
    Gustavson, Stephanie
    Kartman, Bernt
    Wittbrodt, Eric T.
    Mentz, Robert J.
    Pagidipati, Neha
    Bethel, M. Angelyn
    Gray, Alastair M.
    Holman, Rury R.
    Hernandez, Adrian F.
    DIABETES, 2018, 67
  • [45] Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain
    Garcia de Lucas, Maria Dolores
    Pablo Miramontes-Gonzalez, Jose
    Aviles-Bueno, Beatriz
    Isabel Jimenez-Millan, Ana
    Rivas-Ruiz, Francisco
    Perez-Belmonte, Luis M.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [46] Once-Weekly Exenatide in Youth With Type 2 Diabetes
    Tamborlane, William, V
    Bishai, Raafat
    Geller, David
    Shehadeh, Naim
    Al-Abdulrazzaq, Dalia
    Manica Vazquez, Evelina
    Karoly, Eva
    Troja, Tunde
    Doehring, Orlando
    Carter, Debra
    Monyak, John
    Sjostrom, C. David
    DIABETES CARE, 2022, 45 (08) : 1833 - 1840
  • [47] Real-world characteristics of patients with type 2 diabetes initiating insulin glargine plus exenatide or insulin glargine plus liraglutide
    Di Genio, A.
    Ling, Z.
    Davis, K. L.
    Meyers, J. L.
    Dalal, M. R.
    DIABETOLOGIA, 2012, 55 : S328 - S328
  • [48] Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study)
    Mateos, Irene Caballero
    de Lucas, Maria Dolores Garcia
    Doulatram-Gamgaram, Viyey Kishore
    Moreno-Moreno, Paloma
    Jimenez-Millan, Ana Isabel
    Botana-Lopez, Manuel
    Merino-Torres, Juan Francisco
    Soto-Gonzalez, Alfonso
    Fernandez-Garcia, Jose Carlos
    Morales-Portillo, Cristobal
    NUTRIENTS, 2024, 16 (15)
  • [49] Once-weekly exenatide as a treatment for Type 2 diabetes
    Schauerhamer, Marisa B.
    Gurgle, Holly
    McAdam-Marx, Carrie
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (06) : 611 - 626
  • [50] Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
    Seewoodhary, Jason
    Griffin, Leanne
    Bain, Stephen C.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 165 - 172
12345